Idelalisib (trade name Zydelig) is a phosphoinositide 3-kinase inhibitor for the treatment of certain hematological malignancies. Idelalisib has been approved by the U.S Food and Drug Administration on July 23, 2014.
Product Name: Idelalisib
Synonyms: GS-1101; CAL-101
CAS Number: 870281-82-6
Molecular Weight:  415.4289
Molecular Formula:  C22H18FN7O
Purity (HPLC): ≥99%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.